Revolutionary ATP imaging technique sheds light on kidney cell energy production

FHS
July 23, 2024
6:59 am

The prevalence of kidney disease has been increasing in Japan, with it now affecting one in eight adults, but developing effective treatment remains a challenge.

Avidity to raise $400M; Sato pays Arcutis $25M upfront to license topical roflumilast in Japan

Plus, news about Xencor, Otsuka, Typewriter Therapeutics, Cassava Sciences, Enveric Biosciences, Viking Therapeutics and Janux Therapeutics: Next up in the PIPE bonanza: RNA company Avidity

March 1, 2024

Basecamp raises $60M to travel the globe and fill AI data gaps, signs deal with David Liu

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 10, 2024

Upside for competitor manufacturers due to Novo-Catalent deal unlikely to be immediate, Samsung Bio exec says

Even if competitor manufacturers attract the attention of Catalent’s customers on the back of it being acquired by Novo Holdings, it will take time for

March 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.